VX 11106
Latest Information Update: 11 Dec 2006
At a glance
- Originator Vertex Pharmaceuticals
- Developer Kissei Pharmaceutical; Vertex Pharmaceuticals
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Mar 1995 No-Development-Reported for HIV infections treatment in Japan (PO)
- 13 Mar 1995 No-Development-Reported for HIV infections treatment in USA (PO)